Fig. 7From: Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective studyDCA of the nomogram and AJCC TNM staging for 1-year (A), 3-year (B) and 5-year (C) OS in training cohort, and for 1-year (D), 3-year (E) and 5-year (F) OS in the validation cohort. The red dashed line represents the nomogram. The blue dashed line represents AJCC TNM stage. OS, overall survival; DCA, decision curve analyses; AJCC, American Joint Committee on CancerBack to article page